News
Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...
Guggenheim analyst Vamil Divan maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...
NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...
A Merck logo is shown on a scientist's lab coat. The Food and Drug Administration, on Sept. 4, 2014, granted accelerated approval to Merck's Keytruda for treating melanoma that has spread or can't be ...
Hosted on MSN29d
Merck buys rights to heart disease drug in latest China dealMerck last year signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to treat obesity. It also bought the rights to an early-stage cancer drug ...
The California-based surf brand Lost International claim that the singer is ripping off a trademark they've had since 2015 Kevin Mazur/Getty Lost International is suing Lady Gaga for using a logo ...
Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...
Lady Gaga was hit with a $100 million lawsuit by a California surf company over claims the pop star stole their logo for her new merchandise, according to documents obtained by FOX Business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Hosted on MSN29d
Merck signs deal with Jiangsu Hengrui worth up to $2 billion for access to heart drugUnder the terms of the agreement, Merck will get exclusive rights to develop, manufacture and sell the heart disease drug, HRS-5346 worldwide, except in the Greater China region. The oral drug is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results